Cholinergic dependence of taste memory formation: evidence of two distinct processes

Neurobiol Learn Mem. 2003 Nov;80(3):323-31. doi: 10.1016/s1074-7427(03)00066-2.

Abstract

Learning the aversive or positive consequences associated with novel taste solutions has a strong significance for an animal's survival. A lack of recognition of a taste's consequences could prevent ingestion of potential edibles or encounter death. We used conditioned taste aversion (CTA) and attenuation of neophobia (AN) to study aversive and safe taste memory formation. To determine if muscarinic receptors in the insular cortex participate differentially in both tasks, we infused the muscarinic antagonists scopolamine at distinct times before or after the presentation of a strong concentration of saccharin, followed by either an i.p. injection of a malaise-inducing agent or no injection. Our results showed that blockade of muscarinic receptors before taste presentation disrupts both learning tasks. However, the same treatment after the taste prevents AN but not CTA. These results clearly demonstrate that cortical cholinergic activity participates in the acquisition of both safe and aversive memory formation, and that cortical muscarinic receptors seem to be necessary for safe but not for aversive taste memory consolidation. These results suggest that the taste memory trace is processed in the insular cortex simultaneously by at least two independent mechanisms, and that their interaction would determine the degree of aversion or preference learned to a novel taste.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Behavior, Animal / drug effects
  • Choice Behavior / drug effects
  • Cholinergic Fibers / drug effects*
  • Conditioning, Psychological / drug effects
  • Male
  • Memory / drug effects*
  • Muscarinic Antagonists / administration & dosage
  • Muscarinic Antagonists / pharmacology
  • Rats
  • Rats, Wistar
  • Scopolamine / administration & dosage
  • Scopolamine / pharmacology
  • Taste / drug effects*

Substances

  • Muscarinic Antagonists
  • Scopolamine